Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-27, Stock:JNJ, The news for the past five days is as follows:
2018-08-20: NEWS1: MARKETS: Stocks rally but face headline risk in both directions.NEWS2: St. Charles County lawsuit accuses drug companies, distributors of worsening opioid epidemic.NEWS3: 5 Execs Talk Business Models At Cannabis Capital Conference.NEWS4: 5 Hot Stocks in the Dow ETF Last Week.NEWS5: 5 Hot Stocks in the Dow ETF Last Week.NEWS6: Dow Movers: INTC, NKE.NEWS7: Dow Movers: INTC, NKE.NEWS8: XLV, JNJ, UNH, PFE: Large Inflows Detected at ETF.NEWS9: XLV, JNJ, UNH, PFE: Large Inflows Detected at ETF.NEWS10: What You Must Know About Johnson & Johnson’s (NYSE:JNJ) Financial Strength.NEWS11: Allergan’s International Business Segment in Q2 2018.NEWS12: 5 Hot Stocks in the Dow ETF Last Week.NEWS13: Johnson & Johnson to Host Investor Conference Call on the Pharmaceutical Business.NEWS14: Pre-Market Most Active for Aug 20, 2018 :  TSLA, BBOX, AAPL, SODA, LCI, TOT, BABA, QQQ, JNJ, SCZ, BP, LYG.NEWS15: Pre-Market Most Active for Aug 20, 2018 :  TSLA, BBOX, AAPL, SODA, LCI, TOT, BABA, QQQ, JNJ, SCZ, BP, LYG.
2018-08-21: NEWS1: Cramer: Drug stocks' rally doesn't mean a recession is on....NEWS2: Jim Cramer: This Is a Rotation, Not a Recession.NEWS3: 5 Top Stock Trades for Wednesday — How to Trade Kohl’s Earnings Rally.NEWS4: 4 Sector ETFs to Tap at New Highs.NEWS5: 4 Sector ETFs to Tap at New Highs.NEWS6: J&J Stock Is Firming Up Nicely, Stay Long.NEWS7: Glaxo Stock Up This Year So Far: Will the Rally Continue?.NEWS8: Glaxo Stock Up This Year So Far: Will the Rally Continue?.NEWS9: Dow Movers: JNJ, INTC.NEWS10: Dow Movers: JNJ, INTC.
2018-08-22: NEWS1: Jim Cramer: What Does Politics Have to Do With Johnson & Johnson's P/E?.NEWS2: Cramer: Michael Cohen plea and Paul Manafort verdict could have mixed effects on the market.NEWS3: Missouri judge affirms $4.69 billion talc verdict, J&J vows to appeal.NEWS4: Missouri judge affirms $4.69 billion talc verdict, Johnson & Johnson vows to appeal.NEWS5: Missouri judge affirms $4.69 billion talc verdict, J&J vows to appeal.NEWS6: Pacira (PCRX) Rides High on Robust Exparel Performance.NEWS7: Pacira (PCRX) Rides High on Robust Exparel Performance.NEWS8: VIVUS' (VVUS) Qsymia Falters in a Highly Competitive Market.NEWS9: VIVUS' (VVUS) Qsymia Falters in a Highly Competitive Market.NEWS10: Boost Your Portfolio’s Yield by 400% Overnight.NEWS11: Boost Your Portfolio’s Yield by 400% Overnight.NEWS12: 5 Top Stock Trades for Wednesday — How to Trade Kohl’s Earnings Rally.NEWS13: 5 Top Stock Trades for Wednesday — How to Trade Kohl’s Earnings Rally.
2018-08-23: NEWS1: Will Johnson & Johnson (NYSE:JNJ) Continue To Underperform Its Industry?.NEWS2: Analyzing Stryker’s Product Performance.NEWS3: Analyzing Stryker’s Top Line Trend.NEWS4: J&J to Appeal as Judge Confirms Jury Order in Talc Case.NEWS5: J&J to Appeal as Judge Confirms Jury Order in Talc Case.NEWS6: Roche: Recent Developments and Analysts’ Ratings in August.NEWS7: Caldwell Cassady & Curry Helps Acantha Win $8.2 Million Patent Infringement Verdict Against Medical Device Giant DePuy Synthes.NEWS8: Ex-Dividend Reminder: Core Mark Holding, Johnson & Johnson and S&P Global.NEWS9: Ex-Dividend Reminder: Core Mark Holding, Johnson & Johnson and S&P Global.NEWS10: J&J to Appeal as Judge Confirms Jury Order in Talc Case.NEWS11: Large-Cap Pharma Rebounds: 2 Stocks to Boost Your Portfolio.
2018-08-24: NEWS1: Noteworthy Friday Option Activity: JNJ, USB, VLO.NEWS2: Noteworthy Friday Option Activity: JNJ, USB, VLO.NEWS3: Top Research Reports for Johnson & Johnson, NIKE & BP.NEWS4: Top Research Reports for Johnson & Johnson, NIKE & BP.NEWS5: Top Research Reports for Johnson & Johnson, NIKE & BP.NEWS6: 3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them?.NEWS7: 3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them?.NEWS8: TransEnterix Expected to Report Solid Rise in Revenues in 2018.NEWS9: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 27, 2018.NEWS10: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 27, 2018.NEWS11: An Overview of Roche’s Hemato-Oncology Drugs MabThera and Gazvya.NEWS12: 3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them?.NEWS13: What Analysts Recommend for TransEnterix and Peers in August 2018.NEWS14: What Does Stryker’s Valuation Trend Indicate?.

Answer: Decrease